Ajinomoto Cambrooke, Inc. is a leading therapeutic medical nutrition company founded in 2000 by Lynn and David Paolella. The company specializes in developing innovative nutritional formulas and foods for the management of various medical conditions, with a focus on rare diseases like phenylketonuria (PKU). Notably, Cambrooke was the first to launch Glytactin™, a natural intact protein for PKU dietary management. They collaborate with academic and industry partners to bring early phase therapeutic nutrition projects to market, ensuring their products are supported by clinical evidence.
Ajinomoto Cambrooke is seeking a Sr. Engineer Digital Transformation to drive strategic initiatives that align digital capabilities with business goals. The role involves transitioning from traditional methods to digital processes, optimizing digital ecosystems, and ensuring scalable infrastructure. The ideal candidate will be a highly motivated leader and strategist, acting as a cross-functional consultant and liaison between internal teams and external partners.
Ajinomoto Cambrooke, Inc. is a leading therapeutic medical nutrition company founded in 2000 by Lynn and David Paolella. The company specializes in developing innovative nutritional formulas and foods for the management of various medical conditions, with a focus on rare diseases like phenylketonuria (PKU). Notably, Cambrooke was the first to launch Glytactin™, a natural intact protein for PKU dietary management. They collaborate with academic and industry partners to bring early phase therapeutic nutrition projects to market, ensuring their products are supported by clinical evidence.
DigitalOcean